Open access · Peer reviewed · Scopus journal
ACE inhibitor and angiotensin-receptor blocker – A deadly combination
- *
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: G. Sivagnanam
Copyright: © 2011 The Author(s). This is an open access article.
Published: Jan 1, 2011
- DOI
- Not available yet
Abstract
It is particular to note that ACE inhibitor/ARB combination therapy has been shown to offer no signifi cant clinical benefi ts over monotherapy, instead was associated with a worse safety and tolerability profi le. No morbidity and mortality data for direct renin inhibitor (DRI)/ACEI or DRI/ARB combinations are currently available
Keywords
Subject
Recommended articles
- New(s): Are these terms new(s)!?
G. Sivagnanam · Journal of Pharmacology and Pharmacotherapeutics
- Antibiotics with a curse of cardiovascular risk
G Sivagnanam · Journal of Pharmacology and Pharmacotherapeutics
- Acetaminophen associated with risk of hearing loss: A safety alert
Sangeeta Bhanwra, Kaza Ahluwalia · Journal of Pharmacology and Pharmacotherapeutics
- Majority general practitioners prescribe “Impure Placebo” drugs
· Journal of Pharmacology and Pharmacotherapeutics
- A new drug belonging to a novel class of drugs for type 2 diabetes
Sivagnanam G · Journal of Pharmacology and Pharmacotherapeutics
- The enema of your enemy is your friend
· Journal of Pharmacology and Pharmacotherapeutics
Readers Also Viewed
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026
Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia
Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby
Jan 1, 2026